Bard Proposes Ventralight ST & Ventralex Claims For Initial Trials
Bard Proposes Ventralight ST & Ventralex Claims For Initial Trials
Introduction
C.R. Bard and its Davol, Inc. subsidiary have proposed that from over a thousand lawsuits faced by them, claims related to Bard Ventralight ST and Bard Ventralex mesh be the first to go before a jury later this year.
The company faces more than 3,500 lawsuits with similar allegations from plaintiffs due to various hernia polypropylene mesh device, namely Ventralex, Ventralight, PerFix, 3DMax, and other devices. The outcomes of these trials will not be forced on other pending lawsuits. U.S. District Judge Edmund A. Sargus in the Southern District of Ohio will look into the proceedings of the trials which are scheduled to begin on May 11, 2020; July 13, 2020; and September 14, 2020.
Bard has proposed to start the trials with Ventralight ST and Ventralex, as the lawsuits involving these devices are more as compared to other devices, which will ease the process of determining the potential settlement.
Comments
Latest News
NC to Get $150M to Boost Opioid Treatment, Recovery
Categories: Opioids
North Carolina will receive an additional $150 million from Purdue Pharma and the Sackler family as part of a national $7.4 billion settlement related to the opioid…
SRI Gets FDA OK for High-Dose Naloxone Trial
Categories: Opioids
SRI has received authorization from the U.S. Food and Drug Administration (FDA) to begin Phase 1 clinical trials of a new, high-dose injectable naloxone formulation.
The approval was granted under an Investigational New Drug (IND)…
Spokane County to Get $5M in New Opioid Settlement
Categories: Opioids
Jurisdictions within Spokane County are set to receive nearly $4.7 million as part of a sweeping $7.4 billion nationwide settlement with Purdue Pharma and its owners, the Sackler family.
The agreement addresses the company’s role in fueling…